A randomized, double-blindphase 3 study of vadastuximab

  • Bejanyan, Nelli (PI)

Project: Research project

Project Details

Description

A randomized, double-blindphase 3 study of vadastuximab talirine (SGN-CD33A)versus placebo in combination with azacitidine or decitabine in the treatment of older patients with newly diagnosed acute myeloid leukemia (AML) (SGN33A-005)
StatusFinished
Effective start/end date1/1/179/1/17

Funding

  • Seattle Genetics, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.